Lifetime heavy drinking sharply raises colorectal cancer risk, major US study finds
A large US trial shows that the cumulative burden of alcohol over decades matters for colorectal cancer risk,…
Advanced AI provides accurate guidance for prostate cancer patients
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large language model to provide accurate, patient-specific prostate cancer education. The…
Day case surgery linked to significant readmission and chronic pain risks
Two new studies published in Anaesthesia (the journal of the Association of Anaesthetists) analyzing pain and other factors…
Landmark prostate cancer screening trial launches in the UK
The first men have been invited to take part in Prostate Cancer UK’s TRANSFORM trial, kicking off the…
Study uncovers promising therapeutic strategies against neuroendocrine prostate cancer
A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill…
Prostate cancer prevention day at ClÃnica Premium Marbella
Monday, 17 November 2025, 13:11 As part of ‘Movember’, the month dedicated to raising awareness about men’s health,…
National initiative helps reduce missed radiation appointments for cancer patients
A national quality improvement program led by the American College of Surgeons (ACS) found that transportation barriers and…
Age impacts systemic therapy outcomes in metastatic prostate cancer
Many things are evaluated when doctors are putting a treatment plan together for prostate cancer patients. A new…
PTGES3 emerges as key regulator of androgen receptor in prostate cancer
A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player…
Study confirms PSA screening improves survival and safety
The 23-year ERSPC trial reveals that sustained, protocolized PSA testing lowers prostate cancer deaths and improves the benefit-to-harm…
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…